Plexus Corp. $PLXS Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank increased its position in Plexus Corp. (NASDAQ:PLXSFree Report) by 59.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,093 shares of the technology company’s stock after purchasing an additional 3,384 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Plexus were worth $1,337,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of PLXS. Salomon & Ludwin LLC acquired a new position in Plexus in the third quarter worth about $30,000. Allworth Financial LP grew its stake in Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after purchasing an additional 103 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in Plexus in the third quarter worth about $72,000. Farther Finance Advisors LLC grew its stake in Plexus by 114.7% in the fourth quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock worth $75,000 after purchasing an additional 273 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after purchasing an additional 490 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Plexus Stock Up 1.7%

NASDAQ:PLXS opened at $250.60 on Thursday. The firm has a market capitalization of $6.71 billion, a PE ratio of 38.97 and a beta of 0.75. The stock has a 50 day moving average of $210.71 and a 200-day moving average of $177.98. Plexus Corp. has a 52 week low of $115.35 and a 52 week high of $259.05. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXSGet Free Report) last posted its earnings results on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, beating the consensus estimate of $1.88 by $0.17. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.13 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The business’s revenue was up 18.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Analysts predict that Plexus Corp. will post 6.56 EPS for the current year.

More Plexus News

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Company issued upbeat Q3 fiscal 2026 guidance (EPS $2.020–2.180 vs. consensus ~1.93 and revenue guidance $1.2B–$1.3B above street revenue expectations), signaling stronger forward visibility and driving bullish investor reaction. Plexus Announces Fiscal Second Quarter Financial Results
  • Positive Sentiment: Plexus reported record fiscal Q2 revenue of about $1.16B with GAAP operating margin ~5.3% and year-over-year top-line and net income growth — supportive of higher valuation multiples for a services/EMS provider. Plexus Announces Fiscal Second Quarter Financial Results
  • Positive Sentiment: Recent analyst coverage remains constructive (Buy ratings from Needham and Benchmark; several price targets above $200), which can support momentum after strong guidance. QuiverQuant PLXS Coverage
  • Neutral Sentiment: Management announced a planned CFO retirement and a disciplined succession process — a leadership change that appears orderly but bears watching for transition execution. CFO Transition Release
  • Neutral Sentiment: There are conflicting EPS headlines across outlets (a Zacks item reported $2.05 EPS vs. some sources and the company press release showing GAAP diluted EPS of $1.82); investors should rely on the company filing for the definitive numbers. Zacks Article
  • Negative Sentiment: Reported GAAP diluted EPS of $1.82 missed some analyst models (consensus ~ $1.88–1.92 per several outlets), which tempered the immediate reaction despite revenue strength. Plexus Press Release / 10-Q Style Report
  • Negative Sentiment: Quiver and others flag substantial insider selling activity over recent months and a drop in operating cash flow year-over-year — these governance and cash-flow datapoints may concern some investors. QuiverQuant Insider & Financial Summary

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Zacks Research downgraded Plexus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 13th. Needham & Company LLC lifted their price target on Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Stifel Nicolaus set a $250.00 target price on Plexus and gave the company a “buy” rating in a research note on Monday, April 20th. Williams Trading set a $195.00 target price on Plexus in a report on Wednesday, January 28th. Finally, Benchmark reaffirmed a “buy” rating and set a $220.00 target price on shares of Plexus in a report on Monday, March 16th. Four equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $204.20.

Check Out Our Latest Stock Report on PLXS

Insider Activity at Plexus

In other news, Chairman Dean A. Foate sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $204.89, for a total transaction of $1,024,450.00. Following the completion of the transaction, the chairman directly owned 15,000 shares in the company, valued at approximately $3,073,350. The trade was a 25.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Patrick John Jermain sold 4,841 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $204.01, for a total value of $987,612.41. Following the transaction, the chief financial officer owned 20,469 shares of the company’s stock, valued at approximately $4,175,880.69. This represents a 19.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 50,995 shares of company stock valued at $10,345,971. 1.78% of the stock is owned by insiders.

Plexus Profile

(Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.